On December 17, 2013, The Board of Directors of BG Medicine, Inc. approved a change to Stephane Bancel's position within the company from Executive Chairman to Chairman, effective as of November 1, 2013.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2016 | BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015 | CI |
2016 | BG Medicine Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 11 | |
-31.10% | 1.31B | |
-17.87% | 57.8M |
- Stock Market
- Equities
- BGMD Stock
- News BG Medicine, Inc.
- BG Medicine, Inc. Approves a Change to Stephane Bancel’s Position from Executive Chairman to Chairman